HHS0014492 Illumina sequencing kits and reagents

The Texas Health and Human Services Commission (HHSC) and Department of State Health Services (DSHS) are seeking competitive bids to establish a 5-year contract for Illumina sequencing kits and reagents. The contract will provide reagents used for genetic sequencing of genetic material for microorganism serotype and variant surveillance as well as newborn screening across multiple jurisdictions in Texas, including Travis County and the City of Austin. The solicitation, numbered HHS0014492, requires detailed pricing on various Illumina sequencing products such as MiSeq and NovaSeq kits, indexing reagents, and control materials. Responses are due by April 12, 2024, at 10:30 A.M. Central Time. The contract will be awarded based on meeting technical specifications, delivery requirements, and providing the best value to the state, not necessarily the lowest price. Past vendor performance may also be considered in the evaluation.

The solicitation is open to Texas-based vendors, with preferences given to those meeting certain criteria outlined in the Solicitation Affirmations. A HUB Subcontracting Plan is encouraged but not required. The total estimated contract value is $8,625,385 over the 5-year term, with an estimated annual spend of $972,667 for microorganism sequencing and $752,410 for newborn screening. The contract may be subject to various state requirements related to boycotts, discrimination, cybersecurity, and other legislative actions. No incumbent vendor information is provided in the solicitation documents.